Baseler et al., 1983 - Google Patents
Purification of haptoglobin and its effects on lymphocyte and alveolar macrophage responsesBaseler et al., 1983
- Document ID
- 9187626860783272738
- Author
- Baseler M
- Burrell R
- Publication year
- Publication venue
- Inflammation
External Links
Snippet
Clinical observations made on a patient with acute hypersensitivity pneumonitis revealed that the patient's serum contained a mitogenic inhibitor and an extremely high haptoglobin (Hp) level; this led to an investigation of the role of Hp in lymphocyte function. Hp was …
- 210000004698 Lymphocytes 0 title abstract description 50
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/828—Cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
- Y10S435/815—Enzyme separation or purification by sorption
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Baseler et al. | Purification of haptoglobin and its effects on lymphocyte and alveolar macrophage responses | |
Broxmeyer et al. | Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages. | |
EP0197901B1 (en) | Biologically active fragments of the human antihemophilic factor and method for their preparation and pharmaceutical preparations | |
Masson et al. | Lactoferrin, an iron-binbing protein Ni neutrophilic leukocytes | |
Muchmore et al. | Uromodulin: a unique 85-kilodalton immunosuppressive glycoprotein isolated from urine of pregnant women | |
Bokisch et al. | Third component of complement (C3): structural properties in relation to functions. | |
Meilman et al. | Urinary hydroxyproline peptides | |
US4002602A (en) | Ubiquitous immunopoietic polypeptide (UBIP) and methods | |
Brown et al. | Uromodulin, an immunosuppressive protein derived from pregnancy urine, is an inhibitor of interleukin 1. | |
Sandberg et al. | Lymphokine production by C3b-stimulated B cells | |
JPH0244480B2 (en) | ||
Rajapakse et al. | Macrophage migration inhibition test using guinea-pig macrophages and human lymphocytes | |
IE46754B1 (en) | A glycoprotein and process for the production thereof | |
Molnar et al. | The role of an α2-macroglobulin of rat serum in the phagocytosis of colloidal particles | |
Alpert et al. | Immunosuppressive Characteristics of Human AFP: Effect on Tests of Cell Mediated Immunity and Induction of Humam Suppressor Cells | |
Parmely et al. | Effect of α-fetoprotein and other serum factors derived from hepatoma-bearing rats on the mixed lymphocyte response | |
US4167557A (en) | Ubiquitous immunopoietic polypeptide (UBIP) and methods | |
McIntyre et al. | Immunological studies of the human placenta: functional and morphological analysis of pregnancy-associated plasma protein A (PAPP-A). | |
Horstmann et al. | Isolation of rabbit C3, Factor B, and Factor H and comparison of their properties with those of the human analog. | |
EP0190099A2 (en) | Polypeptide factors from colostrum | |
Verma et al. | Antibodies directed toward human erythrocyte Ca2+-ATPase: effect on enzyme function and immunoreactivity of Ca2+-ATPases from other sources | |
Piazolo et al. | Calcium-binding protein in the duodenal mucosa of uremic patients and normal subjects | |
Björklund | A Serum Cytolytic Factor Active against HeLa and Other Established Cell Strains. | |
US4018885A (en) | Steroid-binding globulin and process for preparing it and antibodies thereto | |
EP0002452B1 (en) | Glycoprotein isolated from aloe |